Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine
about
Pharmacokinetics of dihydrocodeine and its active metabolite after single and multiple oral dosingDiclofenac does not interact with codeine metabolism in vivo: a study in healthy volunteersRole of active metabolites in the use of opioidsCodeine and Morphine MetabolismAnalgesics and breast-feeding: safety considerations.Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters.CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.A comparison of the pharmacokinetics of codeine and its metabolites in healthy Chinese and Caucasian extensive hydroxylators of debrisoquine.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.A review of the efficacy and safety of opioid analgesics post-craniotomy.Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.CYP induction-mediated drug interactions: in vitro assessment and clinical implications.Opioid and chronic non-cancer painPharmacogenetics of analgesics: toward the individualization of prescription.Opiates and elderly: use and side effects.Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine use.Guidelines for maternal codeine use during breastfeeding.Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults.Biological pathways and genetic variables involved in pain.Pharmacological Management of Cancer-Related Pain.Confirmation of recent heroin abuse: Accepting the challenge.Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: a pilot study of perceptions and benefits.Formation of morphine from codeine in Chinese subjects of different CYP2D6 genotypes.The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizersChloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.Pharmacokinetics of a novel liquid controlled release codeine formulation.Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease.Analysis of codeine positivity in urine of pain management patients.Rapid simultaneous determination of codeine and morphine in plasma using LC-ESI-MS/MS: application to a clinical pharmacokinetic study.[Genetic polymorphism and drug interactions: their importance in the treatment of pain].Selective effects of somatostatin analogs on human drug-metabolizing enzymes.Pharmacokinetic-pharmacodynamic modeling of the miotic effects of dihydrocodeine in humans.Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study.Pharmacokinetics of naproxen, its metaboliteO-desmethylnaproxen, and their acyl glucuronides in humansEffect of codeine on gastrointestinal motility in relation to CYP2D6 phenotype*
P2860
Q24564973-891B8947-B4A0-403F-A14E-5EC299D8909DQ24805872-ADB87518-7862-438F-8F7A-55573C00CEFDQ28298981-59DA9CD1-1755-49DC-A60F-BB072C55326BQ30230768-5B118B59-33D9-4923-B71A-5E6C0FC948BFQ33999232-5433DEE2-5AED-440D-B28E-2F9C41554FF0Q34071827-90C5F27E-C36E-40B9-8723-7D83F88AA5CBQ34302849-1A445750-24A6-4C31-8474-9447FA93F071Q34358854-60320FEF-AE48-4265-A603-5B3A64D833C3Q35876954-2589DC7C-80A0-4D2D-B62E-487CF2A4FFA1Q35969949-290E0D22-57C9-41B0-8B94-C2A1CDCA4055Q36111225-793E2934-8AC1-41E8-A4B6-4DC03B0FFB1CQ36485692-99F8E7DE-40ED-4636-8DA3-F9CB65A1B79EQ36663226-4A3EE658-E967-437D-8DCA-0A4597DD3257Q37205954-61485C10-5374-4794-83D5-B02E33483BC4Q37237685-C5DB21B5-4E6B-4285-8708-F80362FAC522Q37264538-67585A82-935D-416F-8AE4-734A6DF74648Q37419914-AC5039AA-A56B-449C-9F86-43CF246DC00BQ37703574-BA812233-384E-471D-99D3-1B10ABF28EEFQ37788989-D4F81390-E80D-4890-BFBE-7418779DEE95Q38672359-8E944951-14AC-4F81-93A2-3F646FB65B92Q39417530-2841F229-57AD-459A-80B3-554FB82ED7A8Q39844006-9538A12E-E871-44F2-9A59-295FB9C35888Q40932226-BF9DF945-4083-41C0-96FE-8F6607AD0D2CQ41854197-D0211D6B-B675-4EC1-A25A-BCD6772D1CC6Q41925505-70F0B4AA-6D0E-42C0-B7C0-404A9ACD780FQ42097867-EF4877AE-2977-4F7D-8F2C-E1B65070D59BQ42694816-6999E94C-BF09-4451-9C45-0109D71C9F11Q43235167-3CD0F69E-3D1F-4A6F-8949-15D6EA9F985AQ44688308-3CEE8684-0C69-4203-9DDD-7A76AAB4E215Q46155218-8AFFFE49-B419-453B-ADA0-150AE2429E79Q46724585-E05997D0-9B6A-4272-91C8-056F0FE7ADA8Q50867763-FDBA61A6-73BC-4133-AE1F-2366327B94E6Q51906646-3F418FAF-9442-4F56-8A8E-20F0C787B676Q54766895-1AAC9E6C-BD36-4F5A-87C5-52EC4C3BA237Q56288636-263D91F7-0A33-42E5-A6D6-367F2B98E718Q56832354-2A541AD1-7FE9-4233-B4E7-B5CDD1BF19D9
P2860
Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@ast
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@en
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@nl
type
label
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@ast
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@en
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@nl
prefLabel
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@ast
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@en
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@nl
P2093
P2860
P1476
Pharmacokinetics of codeine an ...... hydroxylators of debrisoquine
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1991.TB05585.X
P407
P577
1991-06-01T00:00:00Z